Study of DISC-0974-201 for IBD and Anemia
Part of Blood & lymphatic, Digestive system clinical trials.
This trial tests a new medicine called DISC-0974-201 for people with inflammatory bowel disease and anemia. It aims to see if the drug can improve anemia symptoms and is for people with mild disease activity who have not responded well to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been diagnosed with Crohn's, ulcerative colitis, or IBD-unclassified (confirmed by endoscopy and biopsy).
- Your anemia is causing symptoms like fatigue, shortness of breath, or dizziness, and your hemoglobin is between 7 and 12 g/dL (women) or 7 and 13 g/dL (men).
- You have mild active IBD (not moderate or severe) and your ferritin level is at least 75 μg/L.
- You have not had IV iron, a blood transfusion, or an erythropoiesis-stimulating agent in the last 30 days, and you are not currently taking a JAK inhibitor.
- You are not pregnant or breastfeeding, and you agree to use effective contraception if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new therapies for people with moderate to severe Crohn's disease or ulcerative colitis. It may help if your standard treatments aren't working well enough.
This trial tests an investigational drug called DISC-0974 for people with myelofibrosis or certain types of MDS who have low red blood cell counts (anemia). The goal is to see if this treatment can help improve anemia and reduce the need for blood transfusions.
This study looks at how certain blood cells change during a severe flare-up of inflammatory bowel disease (IBD), like Crohn's disease or ulcerative colitis. The goal is to better understand inflammation and potentially improve future treatments.
This study tests a new investigational drug called PVT401 in healthy people. It is a first-in-human study to see how the drug is handled by the body and to check for any side effects.
This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.
This trial is testing a new medicine called HS-20106 to see if it can improve anemia (low red blood cells) for people with certain types of MDS. If it works, it might reduce the need for blood transfusions.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.